Journal Article10.1056/NEJM199412083312307
Idiopathic Dilated Cardiomyopathy
951
TL;DR: Idiopathic dilated cardiomyopathy is a primary myocardial disease of unknown cause characterized by left ventricular or biventricular dilatation and impairedMyocardial contractility.
read more
Abstract: Idiopathic dilated cardiomyopathy (IDC) is a primary myocardial disease of unknown cause characterized by left ventricular or biventricular dilatation and impaired myocardial contractility1. Depend...
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Histopathologic findings in explanted heart tissue from patients with end‐stage idiopathic dilated cardiomyopathy
Nicole De Leeuw,Dirk J. Ruiter,Aggie H.M.M. Balk,Nicolaas de Jonge,Willem J. G. Melchers,Jochem M. D. Galama +5 more
TL;DR: The diffuse presence of reactive fibrosis in idiopathic dilated cardiomyopathy patients suggests a more generalised dysfunction that affects the composition of the myocardial extracellular matrix.
138
Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy.
Daniele Andreini,Gianluca Pontone,Mauro Pepi,Giovanni Ballerini,Antonio L. Bartorelli,Alessandra Magini,Carlo Quaglia,Enrica Nobili,Piergiuseppe Agostoni +8 more
TL;DR: Multidetector computed tomography is feasible, safe, and accurate for identification of idiopathic versus ischemic DCM, and may represent an alternative to coronary angiography.
137
Patent
Detachment mechanism for implantable fixation devices
Alfred H. Raschdorf,Troy L. Thornton,Theodore Ketai +2 more
- 26 Feb 2009
TL;DR: In this paper, the authors provide devices, systems and methods for tissue approximation and repair at treatment sites, including endovascular, minimally-invasive, and open surgical procedures.
135
Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?
Raymond J. Kim,Robert M. Judd +1 more
TL;DR: In vivo magnetic resonance imaging of the heart with gadolinium-based contrast agents has been performed since the mid-1980s and recently a number of studies have shown insufficient image contrast between normal and infarcted myocardium.
135
Alcohol abuse and dilated cardiomyopathy in men
TL;DR: In this large series of patients treated with angiotensin-converting enzyme inhibitors and prospectively followed up, excessive alcohol intake was found in about one fourth of cases and persistent alcohol abuse correlated with a worse prognosis and function at follow-up.
133
References
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
TL;DR: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
7.6K
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
TL;DR: The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates in the group given placebo, among patients with asymptomatic left ventricular dysfunction.
3.8K
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
Jay N. Cohn,Gary R. Johnson,Susan Ziesche,Frederick R. Cobb,Gary S. Francis,Felix E. Tristani,Raphael F. Smith,W. Bruce Dunkman,Henry S. Loeb,Maylene Wong,Geetha Bhat,Steven Goldman,Ross D. Fletcher,James J. Doherty,C. Vincent Hughes,Peter E. Carson,Guillermo Cintron,Ralph Shabetai,Clair Haakenson +18 more
TL;DR: The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.
2.8K
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Jay N. Cohn,Donald G. Archibald,Susan Ziesche,Joseph A. Franciosa,W. Eugene Harston,Felix E. Tristani,W. Bruce Dunkman,William R. Jacobs,Gary S. Francis,Kathleen H. Flohr,Steven Goldman,Frederick R. Cobb,Pravin M. Shah,Robert S. Saunders,Ross D. Fletcher,Henry S. Loeb,V. Hughes,Bonnie J. Baker +17 more
TL;DR: The data suggest that the addition of hydralazine and isosorbide dinitrate to the therapeutic regimen of digoxin and diuretics in patients with chronic congestive heart failure can have a favorable effect on left ventricular function and mortality.
2.3K
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Milton Packer,Joseph R. Carver,Richard J. Rodeheffer,Russell J. Ivanhoe,Robert DiBianco,Steven M. Zeldis,Grady H. Hendrix,William J. Bommer,Uri Elkayam,Marrick L. Kukin,George I. Mallis,J. Sollano,James A. Shannon,P. K. Tandon,David L. DeMets +14 more
TL;DR: The findings indicate that despite its beneficial hemodynamic actions, long-term therapy with oral milrinone increases the morbidity and mortality of patients with severe chronic heart failure.
2.2K